BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8714333)

  • 1. Challenges in moving from a traditional therapeutic community to a women and children's TC model.
    Brown VB; Sanchez S; Zweben JE; Aly T
    J Psychoactive Drugs; 1996; 28(1):39-46. PubMed ID: 8714333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the concept-based therapeutic community can no longer be called drug-free.
    Perfas FB; Spross S
    J Psychoactive Drugs; 2007 Mar; 39(1):69-79. PubMed ID: 17523587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are therapeutic communities therapeutic for women?
    Eliason MJ
    Subst Abuse Treat Prev Policy; 2006 Jan; 1():3. PubMed ID: 16722560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse interventions for parents involved in the child welfare system: evidence and implications.
    Osterling KL; Austin MJ
    J Evid Based Soc Work; 2008; 5(1-2):157-89. PubMed ID: 19064448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse issues among women in domestic violence programs: findings from North Carolina.
    Martin SL; Moracco KE; Chang JC; Council CL; Dulli LS
    Violence Against Women; 2008 Sep; 14(9):985-97. PubMed ID: 18703771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of therapeutic engagement in prison-based drug treatment.
    Welsh WN; McGrain PN
    Drug Alcohol Depend; 2008 Aug; 96(3):271-80. PubMed ID: 18486361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic community for substance-abusing pregnant women and women with children: process and outcome.
    Stevens SJ; Arbiter N
    J Psychoactive Drugs; 1995; 27(1):49-56. PubMed ID: 7602440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
    Greenberg B; Hall DH; Sorensen JL
    J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling treatment motivation in substance-abusing women with children.
    Wilke DJ; Kamata A; Cash SJ
    Child Abuse Negl; 2005 Nov; 29(11):1313-23. PubMed ID: 16263166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medicalization of therapeutic communities in the era of health care reform.
    Smith DE
    J Psychoactive Drugs; 2012; 44(2):93-5. PubMed ID: 22880536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experience of drug-dependent adolescents in a therapeutic community.
    Foster M; Nathan S; Ferry M
    Drug Alcohol Rev; 2010 Sep; 29(5):531-9. PubMed ID: 20887577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where do they fit? Specialized services for pregnant women who are drug addicted.
    Siney C
    Pract Midwife; 1998 Oct; 1(10):12-4. PubMed ID: 10026577
    [No Abstract]   [Full Text] [Related]  

  • 15. PAR Village for chemically dependent women. Philosophy and program elements.
    Coletti SD; Schinka JA; Hughes PH; Hamilton NL; Renard CG; Sicilian DM; Urmann CF; Neri RL
    J Subst Abuse Treat; 1995; 12(4):289-96. PubMed ID: 8830156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making evaluation work in a substance abuse treatment program for women with children: Olivia's House.
    Schumacher JE; Siegal SH; Socol JC; Harkless S; Freeman K
    J Psychoactive Drugs; 1996; 28(1):73-83. PubMed ID: 8714336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCCSAPR: a new approach to drug policy research in the twenty-first century. California Collaborative Center for Substance Abuse Policy Research.
    Smith DE; Seymour RB
    J Psychoactive Drugs; 2000; 32(4):359-61. PubMed ID: 11210196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructive conflict and staff consensus in substance abuse treatment.
    Melnick G; Wexler HK; Chaple M; Cleland CM
    J Subst Abuse Treat; 2009 Mar; 36(2):174-82. PubMed ID: 18657943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residential therapeutic communities in the mainstream: diversity and issues.
    De Leon G
    J Psychoactive Drugs; 1995; 27(1):3-15. PubMed ID: 7602438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
    Paddock SM; Edelen MO; Wenzel SL; Ebener P; Mandell W; Dahl J
    Am J Drug Alcohol Abuse; 2007; 33(4):537-46. PubMed ID: 17668339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.